批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2024/06/12 |
SUPPL-10(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2024/06/12 |
SUPPL-7(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2024/06/12 |
SUPPL-5(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2018/12/21 |
ORIG-1(原始申请) |
Approval |
|
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS 剂型/给药途径:FOR SOLUTION;ORAL 规格:236GM/BOT;2.97GM/BOT;6.74GM/BOT;5.86GM/BOT;22.74GM/BOT 治疗等效代码:AA
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
019011 |
001 |
NDA |
GOLYTELY |
POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS |
FOR SOLUTION;ORAL |
236GM/BOT;2.97GM/BOT;6.74GM/BOT;5.86GM/BOT;22.74GM/BOT |
Prescription |
Yes |
Yes |
AA |
1984/07/13
|
BRAINTREE |
090231 |
001 |
ANDA |
PEG 3350 AND ELECTROLYTES |
POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS |
FOR SOLUTION;ORAL |
236GM/BOT;2.97GM/BOT;6.74GM/BOT;5.86GM/BOT;22.74GM/BOT |
Prescription |
No |
No |
AA |
2009/06/01
|
NOVEL LABS INC |
204558 |
001 |
ANDA |
POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES |
POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS |
FOR SOLUTION;ORAL |
236GM/BOT;2.97GM/BOT;6.74GM/BOT;5.86GM/BOT;22.74GM/BOT |
Prescription |
No |
No |
AA |
2018/12/21
|
STRIDES PHARMA |